No Detail Found!

Efficacy of Topical 0.03% Tacrolimus Dermatologic Ointment in Treatment of Vernal Keratoconjunctivitis

Author(s)
Muhammad Adnan Department of Ophthalmology, Islamabad Medical and Dental College, Islamabad, Pakistan
Amena Masrur Department of Ophthalmology, Islamabad Medical and Dental College, Islamabad, Pakistan
Furqan Ahmed Khan Department of Ophthalmology, Islamabad Medical and Dental College, Islamabad, Pakistan
Ali Tayyab Department of Ophthalmology, Islamabad Medical and Dental College, Islamabad, Pakistan
Abstract
Objective: To determine the efficacy of 0.03% Tacrolimus dermatologic ointment in the treatment of Vernal keratoconjunctivitis. Study Design: Cross-sectional. Place and Duration of Study:The study was conducted at Eye Donors Association Hospital, Wah Cantonment from August 2019 to January 2020. Materials and Methods: 103 diagnosed patients ofvernal keratoconjunctivitis, aged 3-16 years, were included in this study. They were treated with 0.03% Tacrolimus dermatologic ointment,applied in the inferior fornix once at night time, for a period of two months. In addition, these patients were also prescribeda topical antihistamine (0.05 % ketotifen eye drops 3 times a day)and preservative free artificial tearsfor symptomatic relief. The patients were evaluated at 4 and 8 weeks after the initiation of treatment. At each follow up the clinical signs were assessed on a slit lamp biomicroscope by a single observer and recorded on a standardized grading sheet. Results: Out of 103 patients, 66% were male and mean age was 9 years (range 3-16 years). The mean baseline scores showed a statistically significant decrease, with the exception of palpebral follicles & limbal Trantas dots after 8 weeks of treatment. Conclusion: 0.03% Tacrolimus dermatologic ointment was found to be safe and effective in the treatment of vernal kerato-conjunctivitis.
Publication Details
Page(s) 139-144
Published Journal: Life and Science, Volume: 2, Issue: 4, Year: 2021

Request the full text from PASTIC

Keywords
Tacrolimus, Vernal keratoconjunctivitis, Steroid Sparing Agent
0

Citations

0

Downloads

51

Views